<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58633">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01815034</url>
  </required_header>
  <id_info>
    <org_study_id>13-083</org_study_id>
    <nct_id>NCT01815034</nct_id>
  </id_info>
  <brief_title>Trancutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations</brief_title>
  <acronym>TCO2</acronym>
  <official_title>Transcutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations: a Joint Quality Initiative Pilot From Cardiac Electrophysiology and Anesthesiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of trancutaneous CO2 (TC02) monitoring to aide in titration of sedation of midazolam and
      fentanyl.  Trancutaneous readings validated with invasively obtained specimens from existing
      arterial sheaths required during AF and VT ablations (trans-septal and retrograde aortic
      respectively)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac electrophysiology procedures are typically performed under moderate (conscious)
      sedation in most centers.  Advantages over general anesthesia include facilitating
      arrhythmia induction, avoidance of intubation and ventilator related complications and
      shorter post-procedure recovery times for most patients.  However, the cumulative
      respiratory depressant effects of fentanyl and midazolam during prolonged procedures can
      rarely cause hypoventilation resulting in hypercapnea and respiratory failure.  Complex
      catheter ablations for atrial fibrillation and ventricular tachycardia can exceed  3-5 hours
      in duration requiring large cumulative doses of midazolam and fentanyl.  End tidal CO2
      monitors, particularly in non-ventilated patients, have limitations and obtaining frequent
      arterial blood gas samples are often impractical. It remains unknown if contemporary
      trancutaneous CO2 monitoring (TCO2)can provide a feasible alternative to avoid over-sedation
      and resultant respiratory complications during complex catheter ablations with sufficient
      agreement to invasively obtained PCO2 data.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Agreement with invasively obtained  PCO2 data within 5 mm Hg</measure>
    <time_frame>up to 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypercapnia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing catheter ablation for artial fibrillation or ventricular tachycardia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing catheter ablation for atrial fibrillation (AF) or ventricular
             tachycardia (VT) under moderate sedation.

        Exclusion Criteria:

          -  Procedures scheduled for general anesthesia
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel J Cantillon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel Cantillon, MD</last_name>
      <phone>216-444-9220</phone>
      <email>Cantild@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Daniel J Cantillon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 18, 2013</lastchanged_date>
  <firstreceived_date>March 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Dan Cantillon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
